Dr. Harriet Borofsky, M.D.
What this data tells you about Dr. Borofsky
Dr. Harriet Borofsky is a radiation oncology specialist in San Mateo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Borofsky performed 3,047 Medicare services across 2,992 unique beneficiaries.
Between the years covered by Open Payments, Dr. Borofsky received a total of $28,094 from 7 pharmaceutical and/or device companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Borofsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Screening mammography An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease. |
975 | $38 | $129 |
| 3D screening mammography (tomosynthesis) A screening imaging test of the breast using 3D technology to detect potential abnormalities. |
973 | $31 | $102 |
| Digital breast tomosynthesis (3D mammogram) A specialized imaging test that creates three-dimensional pictures of the breast tissue to help detect abnormalities. |
237 | $23 | $103 |
| Complete breast ultrasound, 1 breast A complete ultrasound examination of one breast to visualize internal structures. |
188 | $40 | $174 |
| Diagnostic mammography of 1 breast An X-ray examination of one breast to evaluate specific breast symptoms or abnormalities. |
187 | $31 | $134 |
| Diagnostic mammography of both breasts | 149 | $38 | $164 |
| Limited ultrasound of 1 breast A focused ultrasound examination of a single breast to evaluate specific areas of concern. |
104 | $29 | $132 |
| MRI scan of both breasts A magnetic resonance imaging test that creates detailed pictures of both breasts to help evaluate breast tissue. |
100 | $87 | $364 |
| Breast biopsy with ultrasound-guided localization device placement This procedure involves taking a tissue sample from a breast growth and placing a marker device to locate it, guided by ultrasound imaging. |
41 | $127 | $1,827 |
| X-ray of surgical specimen | 34 | $12 | $53 |
| Breast biopsy with localization device using X-ray A procedure to remove a sample of breast tissue for testing, using X-ray guidance to place a device that marks the location of the first growth. |
30 | $140 | $1,760 |
| Breast lesion localization with ultrasound guidance A device is placed in the breast to mark a specific growth using ultrasound guidance. This procedure helps identify the exact location of the lesion for further treatment or removal. |
18 | $65 | $1,324 |
| MRI-guided breast biopsy with locating device A biopsy of a breast growth is performed using MRI guidance, and a locating device is placed in the tissue. |
11 | $145 | $2,855 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2018-2024) ›
Associated products mentioned in payments ›
The majority of payments (76%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for radiation oncology in CA.
Geographic Context
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Borofsky is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 5% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Borofsky experienced with screening mammography?
Does Dr. Borofsky receive payments from pharmaceutical companies?
How do Dr. Borofsky's costs compare to other radiation oncologists in San Mateo?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology